Supplier Type
- Trader
- Manufacturer
- contract manufacturer
- Reagent
- custom synthesis
Supplier Region
- Mumbai(21)
- Hyderabad(12)
- New Delhi(3)
- Maharashtra(11)
- Kolkata(1)
- Andhra Pradesh(1)
- Gujarat(10)
- Bangalore(1)
- Pune(2)
- Delhi(4)
- Karnataka(1)
- Tamil Nadu(1)
- Telangana(1)
- West Bengal(1)
- Ahmedabad(2)
- Vadodara(2)
- Beijing(1)
- Nagpur(1)
- Punjab(2)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Heat resistant injection stage
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- >99.9%
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.42%
- 99.29%
- 99.00%
- 99%
- 98.60%
- 98.5%
- 98.12%
- 98%
- 98 %
- 97-99%
- 97.57%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96%
- 95.00%
- 95% & 99%
- 95% & 97%
- 95% & 2.0M
- 95% & 1.0M
- 95%
- >95%
- 95 %
- 94.00%
- >92%
- >90%
- 90%
- 90 % Above
- 90 %
- 85% DYE CONTENT
- 8%
- 60-65%
- 50%
- 40%
- 4%/8% & 1.6M
- 3.2M
- 3.0M
- 25.0 - 50.0 %
- 25%/40%/95%/99% & 0.6M/2.15M
- 25% & 1.0M/1.8M
- 25% & 1.0M
- 25%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 21%/25%
- 20%/97% & 1.0M
- 20%/95% & 1.0M
- 20%/24%
- 20% /25%/ 1.2M/1.4M
- 20% & 2.0M
- 20%
- 2.0M
- 15%/23%/33%
- 15%/20%/23%/30% & 1.6M
- 15%
- 12%/15%
- 12%
- 10%/99%
- 10% & 2.0M
- 1.8M/ 2.0M
- 1.8M
- 1.3M
- 1.2M
- 1.0M/3.0M/ 3.2M
- 1.0M/3.0M
- 1.0M/2.0M/ 7.0M
- 1.0M/2.0M/ 2.9M/3.0M
- 1.0M/2.0M
- 1.0M/0.5M
- 1.0M
- 0.7M in
- 0.5M/2.0M/ 2.8M
- 0.5M/1.0M/ 3.0M/3.4M
- 0.5M/1.0M/ 2.0M
- 0.5M/1.0M
- 0.5M in
- 0.5M
- 0.50M
- 0.25M
- 0.1M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 5g
- 25g
- 100ml
- 500ml
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 1and gm
- 1MT
- 95NLT %
- 250250 mg.
-
Manganate(1-), hexakis[μ-(acetato-κO:κO')]bis(acetato-κO)-μ3-oxotri-, hydrogen (1:1), homopolymer
26935-72-8
-
Ammonium ferric citrate
1185-57-5
-
Apixaban
503612-47-3
-
Ferric oxide
1309-37-1
-
Bismuth(III) Oxide
1304-76-3
-
CERIUM(III) CHLORIDE HEPTAHYDRATE
18618-55-8
-
Dysprosium oxide
1308-87-8
-
Ferric nitrate nonahydrate
7782-61-8
-
Ferric chloride
7705-08-0
-
Bismuth nitrate pentahydrate
10035-06-0
Manganese(III) acetate 26935-72-8
Ammonium iron(III) citrate 1185-57-5
Apixaban 503612-47-3
Iron(III) oxide 1309-37-1
Bismuth(III) oxide 1304-76-3
Cerium(III) chloride heptahydrate 18618-55-8
Ammonium iron(III) citrate 1185-57-5
Dysprosium(III) oxide 1308-87-8
Tigecycline EP Impurity C (HCl salt) 13614-98-7
Irinotecan Impurity L (HCl Salt) 1992961-26-8